respiratory health
COPD and the pharmacist’s role
Chronic obstructive pulmonary disease (COPD) is a complex, chronic disease state that requires balancing lifestyle changes and multiple medications. Community pharmacists have an important role in counselling on medication adherence …
Exercise-induced bronchoconstriction
Pharmacists have a key role in identifying persons who may be experiencing exercise-induced bronchoconstriction. By Karalyn Huxhagen BPharm, FPS, AACPA, community pharmacist and accredited consultant pharmacist Learning Objectives After completing …
Pharmacist named NAC Clinical Executive Lead
Veteran advanced practice pharmacist and respiratory health specialist, Debbie Rigby, will join the National Asthma Council of Australia (NAC) as the organisation’s inaugural Clinical Executive Lead. Announcing Ms Rigby’s …
Allergic rhinitis: quality of life impact on patients
As the most accessible healthcare professional, pharmacy teams can play a vital role in patients’ management of allergic rhinitis. By Chrysa Giannellis, consultant pharmacist and managing director, Hummingbird Pharmaceutical Consulting …
Managing the burden of comorbidities in Allergy Rhinitis: a focus on asthma, rhinosinusitis, otitis media and mental health considerations
Pharmacists must be able to correctly diagnose and appropriately treat allergic rhinitis to ensure that the most appropriate treatment option is selected, considering patient-centred management. By Yee Mellor BPharm, MCncrSc, …
Inhaler demand spiked during 2019-20 bushfires: report
A new report from the Australian Institute of Health and Welfare shows increases in emergency department visits for respiratory problems and sales of asthma medication in regions affected by the …
Pharmacists in proactive respiratory wellness
Only 5% of pharmacists currently proactively discuss the impact of air pollution on their patients’ respiratory health, a new report reveals A wider role for community pharmacists in reducing the …
Bushfire disaster: the impact of smoke
Smoke from the disastrous 2019-20 bushfire season caused more than 400 excess deaths, new research has found Researchers led by Nicolas Borchers Arriagada, a PhD candidate with the Menzies Institute …
Arrotex bolsters pharmacy offering
Following the merger of Apotex and Arrow, the combined Arrotex entity now has a considerable portfolio of respiratory medicines – including two new products Arrotex Pharmaceuticals has announced a strategic …
Triple therapy for COPD superior: study
New research published in the New England Journal of Medicine has shown triple therapy better reduces moderate/severe exacerbations compared with dual therapy Results from the IMPACT study, one of the …
Bushfire respiratory warning
With fires burning around Victoria, one expert has warned people with respiratory illness to take care With the mercury topping 40 degrees C in Melbourne today ahead of an expected …
One in six in study had undiagnosed COPD
A new study involving current and former heavy smokers suggests that COPD is being systematically misdiagnosed The researchers, from Monash University, set out to review the accuracy of diagnoses of …